Evidence map›Paper›PMID 36759576›Full record

ArticleOncogene2023

Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.

Hassan Yousefi, Maninder Khosla, Lothar Lauterboeck, Samuel C Okpechi, David Worthylake, Jone Garai, Jovanny Zabaleta, Jessie Guidry, Mohammad Amin Zarandi, Dorota Wyczechowska and 4 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Hassan YousefiDepartment of Biochemistry & Molecular Biology, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA.
Maninder KhoslaDepartment of Biochemistry & Molecular Biology, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA.
Lothar LauterboeckDepartment of Pharmacology and Experimental Therapeutics, Cardiovascular Center of Excellence, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA.
Samuel C OkpechiDepartment of Biochemistry & Molecular Biology, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA.
David WorthylakeDepartment of Biochemistry & Molecular Biology, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA.
Jone GaraiStanley S. Scott Cancer Center, LSUHSC, New Orleans, LA, USA.
Jovanny ZabaletaDepartment of Interdisciplinary Oncology and Stanley S. Scott Cancer Center, LSUHSC, New Orleans, LA, USA.
Jessie GuidryProteomics Core facility, Louisiana State University Health Science Center (LSUHSC), New Orleans, LA, USA.
Mohammad Amin ZarandiDepartment of Chemistry, Tulane University, New Orleans, LA, USA.
Dorota WyczechowskaStanley S. Scott Cancer Center, LSUHSC, New Orleans, LA, USA.
Janarthanan JayawickramarajahDepartment of Chemistry, Tulane University, New Orleans, LA, USA.
Qinglin YangDepartment of Pharmacology and Experimental Therapeutics, Cardiovascular Center of Excellence, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA.
Joseph KissilDepartment of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Suresh K AlahariDepartment of Biochemistry & Molecular Biology, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA. salaha@lsuhsc.edu.ORCID http://orcid.org/0000-0002-9651-6727

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36759576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.